Pharmacokinetics and pharmacodynamics of six epoetin alfa dosing regimens in anemic critically ill patients without acute blood loss. (abre una nueva ventana)

Arroliga AC, Guntupalli KK, Beaver JS, Langholff W, Marino K, Kelly K

Fuente‎: Crit Care Med 2009;37(4):1299-307.

Indexado en‎: PubMed 19242343

DOI‎: 10.1097/CCM.0b013e31819cec94

https://www.ncbi.nlm.nih.gov/pubmed/19242343 (abre una nueva ventana)

Recombinant human erythropoietin therapy in critically ill Jehovah's Witnesses. (abre una nueva ventana)

Ball AM, Winstead PS.

Fuente‎: Pharmacotherapy 2008;28(11):1383-90.

Indexado en‎: PubMed 18956998

DOI‎: 10.1592/phco.28.11.1383

https://www.ncbi.nlm.nih.gov/pubmed/18956998 (abre una nueva ventana)

Reducing postburn injury anemia in a Jehovah's Witness patient. (abre una nueva ventana)

Barsun A, Sen S, Palmieri TL, Greenhalgh DG

Fuente‎: J Burn Care Res 2014;35(4):e258-61.

Indexado en‎: PubMed 24121804

DOI‎: 10.1097/BCR.0b013e3182a366c5

https://www.ncbi.nlm.nih.gov/pubmed/24121804 (abre una nueva ventana)

A US multicenter, retrospective, observational study of erythropoiesis-stimulating agent utilization in anemic, critically ill patients admitted to the intensive care unit. (abre una nueva ventana)

Brophy GM, Sheehan V, Shapiro MJ, Lottenberg L, Scarlata D, Audhya P; ASSESS Study Group and Amgen Inc

Fuente‎: Clin Ther 2008;30(12):2324-34.

Indexado en‎: PubMed 19167591

DOI‎: 10.1016/j.clinthera.2008.12.024

https://www.ncbi.nlm.nih.gov/pubmed/19167591 (abre una nueva ventana)

Severe acute anemia after liver transplantation in an elderly Jehovah's Witness treated with high-dose erythropoietin and ferric carboxymaltose: a case report. (abre una nueva ventana)

Brunetta DM, Kaufman J, De Santis GC, Mesquita DF, Souza FN, Garcia JH.

Fuente‎: Transplant Proc 2015;47(8):2548-51.

Indexado en‎: PubMed 26518969

DOI‎: 10.1016/j.transproceed.2015.09.014

https://www.ncbi.nlm.nih.gov/pubmed/26518969 (abre una nueva ventana)

Recombinant human erythropoietin in severe anaemia: issues of dosing and duration. (abre una nueva ventana)

Charles A, Purtill M, Napolitano LM.

Fuente‎: Anaesth Intensive Care 2006;34(6):793-6.

Indexado en‎: PubMed 17183900

https://www.ncbi.nlm.nih.gov/pubmed/17183900 (abre una nueva ventana)

Efficacy of recombinant human erythropoietin in the critically ill patient: a randomized, double-blind, placebo-controlled trial. (abre una nueva ventana)

Corwin HL, Gettinger A, Rodriguez RM, Pearl RG, Gubler KD, Enny C, Colton T, Corwin MJ.

Fuente‎: Crit Care Med 1999;27(11):2346-50.

Indexado en‎: PubMed 10579246

https://www.ncbi.nlm.nih.gov/pubmed/10579246 (abre una nueva ventana)

Erythropoietin for critically ill trauma patients: a missed opportunity? (abre una nueva ventana)

Corwin HL, Napolitano LM

Fuente‎: J Trauma Acute Care Surg 2014;77(5):774-9.

Indexado en‎: PubMed 25494432

DOI‎: 10.1097/TA.0000000000000442

https://www.ncbi.nlm.nih.gov/pubmed/25494432 (abre una nueva ventana)

Postoperative management of severe acute anemia in a Jehovah's Witness. (abre una nueva ventana)

de Araújo Azi LM, Lopes FM, Garcia LV

Fuente‎: Transfusion 2014;54(4):1153-7.

Indexado en‎: PubMed 24117834

DOI‎: 10.1111/trf.12424

https://www.ncbi.nlm.nih.gov/pubmed/24117834 (abre una nueva ventana)

Restrictive transfusion in geriatric trauma patients. (abre una nueva ventana)

DeLeon AN, Uecker JM, Stafford SV, Ali S, Clark A, Brown CV

Fuente‎: Am Surg 2016;82(1):85-8.

Indexado en‎: PubMed 26802863

https://www.ncbi.nlm.nih.gov/pubmed/26802863 (abre una nueva ventana)

High-dose recombinant human erythropoietin stimulates reticulocyte production in patients with multiple organ dysfunction syndrome. (abre una nueva ventana)

Gabriel A, Kozek S, Chiari A, Fitzgerald R, Grabner C, Geissler K, Zimpfer M, Stockenhuber F, Bircher NG

Fuente‎: J Trauma 1998;44(2):361-7.

Indexado en‎: PubMed 9498512

DOI‎: 10.1097/00005373-199802000-00023

https://www.ncbi.nlm.nih.gov/pubmed/9498512 (abre una nueva ventana)

Recombinant human erythropoietin therapy in critically ill patients: a dose-response study [ISRCTN48523317]. (abre una nueva ventana)

Georgopoulos D, Matamis D, Routsi C, Michalopoulos A, Maggina N, Dimopoulos G, Zakynthinos E, Nakos G, Thomopoulos G, Mandragos K, Maniatis A; Critical Care Clinical Trials Greek Group.

Fuente‎: Crit Care 2005;9(5):R508-15.

Indexado en‎: PubMed 16277712

DOI‎: 10.1186/cc3786

https://www.ncbi.nlm.nih.gov/pubmed/16277712 (abre una nueva ventana)

Management of a Jehovah's Witness patient with sepsis and profuse bleeding after emergency coronary artery bypass graft surgery: rethinking the critical threshold of oxygen delivery. (abre una nueva ventana)

Hong T, Shander A, Agarwal S, Castresana M.

Fuente‎: A A Case Rep 2015;4(10):127-31.

Indexado en‎: PubMed 25974416

DOI‎: 10.1213/XAA.0000000000000144

https://www.ncbi.nlm.nih.gov/pubmed/25974416 (abre una nueva ventana)

Management strategies for perioperative anaemia in the severely burn-injured Jehovah's Witness patients who decline a blood transfusion: a systematic review with illustrative case reports. (abre una nueva ventana)

Jung M, Harish V, Wijewardena A, Kerridge I, Gillies R

Fuente‎: Burns. 2023 49(3):716-29. Epub 2022 Jul 18.

Indexado en‎: PubMed 35941026

DOI‎: 10.1016/j.burns.2022.07.002

https://pubmed.ncbi.nlm.nih.gov/35941026/ (abre una nueva ventana)

Long-term ECMO treatment in Jehovah's Witness patient without transfusions. (abre una nueva ventana)

Lindholm J, Palmér K, Frenckner B.

Fuente‎: Perfusion 2012;27(4):332-4.

Indexado en‎: PubMed 22496111

DOI‎: 10.1177/0267659112444328

https://www.ncbi.nlm.nih.gov/pubmed/22496111 (abre una nueva ventana)

Outcomes with the use of recombinant human erythropoietin in critically ill burn patients. (abre una nueva ventana)

Lundy JB, Hetz K, Chung KK, Renz EM, White CE, King BT, Huzar T, Wolf SE, Blackbourne LH

Fuente‎: Am Surg 2010;76(9):951-6.

Indexado en‎: PubMed 20836341

https://www.ncbi.nlm.nih.gov/pubmed/20836341 (abre una nueva ventana)

Safety of off-label erythropoiesis stimulating agents in critically ill patients: a meta-analysis. (abre una nueva ventana)

Mesgarpour B, Heidinger BH, Schwameis M, Kienbacher C, Walsh C, Schmitz S, Herkner H.

Fuente‎: Intensive Care Med 2013;39(11):1896-908.

Indexado en‎: PubMed 23928897

DOI‎: 10.1007/s00134-013-3030-9

https://www.ncbi.nlm.nih.gov/pubmed/23928897 (abre una nueva ventana)

Transfusion-free treatment strategies for acute anemia in critical care. (abre una nueva ventana)

Morgan CA, Byul Sarah S, Forest CP.

Fuente‎: JAAPA 2016;29(8):38-44.

Indexado en‎: PubMed 27467297

DOI‎: 10.1097/01.JAA.0000488695.96294.33

https://www.ncbi.nlm.nih.gov/pubmed/27467297 (abre una nueva ventana)

Improved survival of critically ill trauma patients treated with recombinant human erythropoietin. (abre una nueva ventana)

Napolitano LM, Fabian TC, Kelly KM, Bailey JA, Block EF, Langholff W, Enny C, Corwin HL.

Fuente‎: J Trauma 2008;65(2):285-97.

Indexado en‎: PubMed 18695463

DOI‎: 10.1097/TA.0b013e31817f2c6e

https://www.ncbi.nlm.nih.gov/pubmed/18695463 (abre una nueva ventana)

Reticulocyte counts and their relation to hemoglobin levels in trauma patients. (abre una nueva ventana)

Otterman ML, Nijboer JM, van der Horst IC, van Meurs M, ten Duis HJ, Nijsten MW

Fuente‎: J Trauma 2009;67(1):121-4.

Indexado en‎: PubMed 19590320

DOI‎: 10.1097/TA.0b013e318187a848

https://www.ncbi.nlm.nih.gov/pubmed/19590320 (abre una nueva ventana)

Randomized, double-blind, placebo-controlled trial of effects of enteral iron supplementation on anemia and risk of infection during surgical critical illness. (abre una nueva ventana)

Pieracci FM, Henderson P, Rodney JR, Holena DN, Genisca A, Ip I, Benkert S, Hydo LJ, Eachempati SR, Shou J, Barie PS.

Fuente‎: Surg Infect (Larchmt) 2009;10(1):9-19.

Indexado en‎: PubMed 19245362

DOI‎: 10.1089/sur.2008.043

https://www.ncbi.nlm.nih.gov/pubmed/19245362 (abre una nueva ventana)

How do we treat life-threatening anemia in a Jehovah's Witness patient? (abre una nueva ventana)

Posluszny JA Jr, Napolitano LM.

Fuente‎: Transfusion 2014;54(12):3026-34.

Indexado en‎: PubMed 25330835

DOI‎: 10.1111/trf.12888

https://www.ncbi.nlm.nih.gov/pubmed/25330835 (abre una nueva ventana)

Recombinant human erythropoietin use in a critically ill Jehovah's Witness after cardiac surgery. (abre una nueva ventana)

Price S, Pepper JR, Jaggar SI.

Fuente‎: Anesth Analg 2005;101(2):325-7.

Indexado en‎: PubMed 16037136

DOI‎: 10.1213/01.ANE.0000159158.70532.D0

https://www.ncbi.nlm.nih.gov/pubmed/16037136 (abre una nueva ventana)

Successful rescue therapy for severe acute anemia: managing the critically ill Jehovah's Witness. (abre una nueva ventana)

Rebel A, Beck A, Efron P, Bavry AA, Ang D.

Fuente‎: Am Surg 2015;81(6):e263-5.

Indexado en‎: PubMed 26031262

https://www.ncbi.nlm.nih.gov/pubmed/26031262 (abre una nueva ventana)

Erythropoietin response is blunted in critically ill patients. (abre una nueva ventana)

Rogiers P, Zhang H, Leeman M, Nagler J, Neels H, Mélot C, Vincent JL

Fuente‎: Intensive Care Med 1997;23(2):159-62.

Indexado en‎: PubMed 9069000

DOI‎: 10.1007/s001340050310

https://www.ncbi.nlm.nih.gov/pubmed/9069000 (abre una nueva ventana)

Life-threatening postoperative blood loss in a Jehovah's Witness, treated with high-dose erythropoietin. (abre una nueva ventana)

Schälte G, Janz H, Busse J, Jovanovic V, Rossaint R, Kuhlen R.

Fuente‎: Br J Anaesth 2005;94(4):442-4.

Indexado en‎: PubMed 15653706

DOI‎: 10.1093/bja/aei068

https://www.ncbi.nlm.nih.gov/pubmed/15653706 (abre una nueva ventana)

Management of anemia in patients who decline blood transfusion. (abre una nueva ventana)

Shander A, Goodnough LT

Fuente‎: Am J Hematol 2018;93(9):1183-91.

Indexado en‎: PubMed 30033541

DOI‎: 10.1002/ajh.25167

https://pubmed.ncbi.nlm.nih.gov/30033541/ (abre una nueva ventana)

Erythropoiesis-stimulating agent administration and survival after severe traumatic brain injury: a prospective study. (abre una nueva ventana)

Talving P, Lustenberger T, Inaba K, Lam L, Mohseni S, Chan L, Demetriades D.

Fuente‎: Arch Surg 2012;147(3):251-5.

Indexado en‎: PubMed 22430906

DOI‎: 10.1001/archsurg.2011.1838

https://www.ncbi.nlm.nih.gov/pubmed/22430906 (abre una nueva ventana)

Intravenous iron following cardiac surgery does not increase the infection rate. (abre una nueva ventana)

Torres S, Kuo YH, Morris K, Neibart R, Holtz JB, Davis JM.

Fuente‎: Surg Infect (Larchmt) 2006;7(4):361-6.

Indexado en‎: PubMed 16978079

DOI‎: 10.1089/sur.2006.7.361

https://www.ncbi.nlm.nih.gov/pubmed/16978079 (abre una nueva ventana)

Erythropoietin improves long-term neurological outcome in acute ischemic stroke patients: a randomized, prospective, placebo-controlled clinical trial. (abre una nueva ventana)

Tsai TH, Lu CH, Wallace CG, Chang WN, Chen SF, Huang CR, Tsai NW, Lan MY, Sung PH, Liu CF, Yip HK

Fuente‎: Crit Care 2015;19:49.

Indexado en‎: PubMed 25888250

DOI‎: 10.1186/s13054-015-0761-8

https://www.ncbi.nlm.nih.gov/pubmed/25888250 (abre una nueva ventana)

Pharmacotherapy for reducing RBC transfusion for patients in the ICU: a systematic review and network meta-analysis. (abre una nueva ventana)

Yoshihiro S, Hongo T, Yamamoto M, Taito S, Kataoka Y

Fuente‎: Crit Care Med 2024;52(4):618-25.

Indexado en‎: PubMed 37962159

DOI‎: 10.1097/CCM.0000000000006114

https://pubmed.ncbi.nlm.nih.gov/37962159/ (abre una nueva ventana)